跳至主要内容
临床试验/NCT02800135
NCT02800135终止不适用

Performance of Diuretic Stress Test in Predicting Short Term Renal Recovery in Oliguric Critically-ill Patients

Centre Hospitalier Universitaire de Saint Etienne4 个研究点 分布在 1 个国家目标入组 93 人开始时间: 2016年4月11日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
终止
入组人数
93
试验地点
4
主要终点
Number of patients with renal recovery

研究概览

简要总结

Acute kidney injury (AKI) is a common disorder and associated with high morbidity and mortality. However, distinguishing transient AKI from persistent AKI may help in individualizing treatment and limit short and long term consequences of AKI. Previous studies suggested usual urinary indices to perform poorly for separating transient from persistent AKI in an unselected population of critically ill patients. The recent KDIGO (Kidney Disease Improving Global Outcomes) guidelines underlined the need for additional strategies in estimating renal short term prognosis.

Recently, a Furosemide stress test (FST) was validated in a cohort of unselected critically ill patients. This stress test performance was found to be good in predicting capacity to identify those patients that will progress to advanced stage AKI. Additionally, FST performance was higher than those of usual renal biomarker. The limited sample size of this preliminary study however precluded adjustment for usual confounders including oliguria.

The primary objective of this study is to assess diagnostic performance of FST in differentiating transient and persistent AKI. Secondary objectives are to assess diagnostic performance of FST in predicting need for renal replacement therapy, and to confirm FST results after adjustment for confounders.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (age > 18 y.o)
  • AKI stage 1 or more according to KDIGO
  • Oliguria as defined by an oliguria lower than 0.5 mL/Kg
  • Affiliation to the National Medical Insurance

排除标准

  • Pregnancy
  • Chronic kidney disease stage 4 or more
  • Need for fluid bolus (>1000 mL crystalloids or equivalent) or need for vasopressors increases or introduction in the 2 hours preceding inclusion
  • Evidence of obstructive renal failure

研究组 & 干预措施

Furosemide stress test

Experimental

干预措施: Furosemide (Drug)

结局指标

主要结局

Number of patients with renal recovery

时间窗: day 3

次要结局

  • natriuresis(mmol/L)(day 0 to day 3)
  • U/P creatinine ratio (mg.dl-1/ mg.dl-1)(day 0 to day 3)
  • fractional excretion of sodium(%)(day 0 to day 3)
  • U/P urea ratio(mg.dl-1/ mg.dl-1)(day 0 to day 3)
  • fractional excretion of urea (%),(day 0 to day 3)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Performance of Diuretic Stress Test in Predicting... | 临床试验